West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

Brown Advisory Sustainable Growth I

US Small-Cap Growth II Equity Comp

AB Large Cap Growth A

ProShares S&P 500 Dividend Aristocrats

BlackRock Mid-Cap Growth Equity Instl

The Health Care Select Sector SPDR® ETF

Vanguard Mid-Cap Growth ETF

Artisan U.S. Mid-Cap Growth

Artisan Mid Cap Investor

Vanguard Institutional Index I

Vanguard Mid Cap Index Institutional

Franklin Rising Dividends Fund A

SPDR® S&P 500® ETF Trust

Fidelity 500 Index

Vanguard Growth Index Investor

Findlay Park American I USD Dist

AllianceBernstein US L/C Growth Eqty MF

iShares Core S&P 500 ETF

Vanguard Group Inc

BlackRock Inc

T. Rowe Price Associates, Inc.

ProShare Advisors LLC

Durable Capital Partners LP

Morgan Stanley - Brokerage Accounts

JPMorgan Chase & Co

NORGES BANK

T. Rowe Price Investment Management,Inc.

Findlay Park Partners LLP

Amvescap Plc.

UBS Asset Mgmt Americas Inc

Bank of New York Mellon Corp

State Street Corp

Artisan Partners Limited Partnership

AllianceBernstein L.P.

Apg All Pensions Group

Brown Advisory Holdings Inc

Franklin Resources Inc

Geode Capital Management, LLC

West Pharmaceutical Services Inc

Mr. Eric M. Green

Non-Independent Chair of the Board, President & CEO

Mr. Bernard J. Birkett

Senior VP & CFO

Mr. Silji  Abraham

Senior VP & CTO

Ms. Kimberly Banks MacKay

Senior VP, General Counsel & Company Secretary

Ms. Cindy  Reiss-Clark

Senior VP & Chief Commercial Officer

Mr. Chad R. Winters

VP, Chief Accounting Officer & Corporate Controller

Mr. John P. Sweeney C.F.A.

Head of Investor Relations

Michele  Polinsky

Vice President of Global Communications

Mr. Rudy  Poussot

Senior VP of Strategy & Corporate Development

Ms. Annette F. Favorite

Chief Human Resources Officer & Senior VP

WST's next earnings is on February 13, 2025 (Before Market Open)

WST's latest dividend is 0.2 USD on July 31, 2024

West Pharmaceutical Services Inc (WST) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

West Pharmaceutical Services Inc (WST) Earnings Report Date and History | NYSE

WST's next earnings is on February 13, 2025 (Before Market Open)

When is the earnings report for WST?

WST Earnings History

WST's latest dividend is 0.2 USD on July 31, 2024

WST Stock Discussion Forum and Message Board

News for NYSE: WST